Business Context and Reporting Period
Company: Astro-Med, Inc. (Note: Request metadata listed "Astronova, Inc.", but the filing is for Astro-Med, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: August 4, 2007
Business Overview: The company develops and manufactures data acquisition, processing, and analysis systems. It operates through three segments: Test & Measurement (T&M), QuickLabel Systems (QLS), and Grass Technologies (GT). Products serve clinical medicine, research, aerospace, automotive, and general manufacturing markets.
Key Financial Metrics
| Metric | Three Months Ended Aug 4, 2007 |
Six Months Ended Aug 4, 2007 |
|---|---|---|
| Net Sales | $18,694,484 | $35,101,374 |
| Gross Profit | $7,830,560 | $14,676,864 |
| Gross Margin | 41.9% | 41.8% |
| Operating Income | $1,262,250 | $1,883,661 |
| Net Income | $885,744 | $1,407,743 |
| Diluted EPS | $0.12 | $0.19 |
| Cash & Equivalents | $3,824,049 | $3,824,049 (Balance Sheet) |
| Total Current Assets | $44,708,802 | $44,708,802 |
| Total Current Liabilities | $7,546,283 | $7,546,283 |
| Long-Term Debt | $0 | $0 |
Liquidity: The company maintains a $3.5 million unsecured bank line of credit, all of which is currently available. Cash and cash equivalents plus securities available for sale totaled approximately $15.9 million at period end.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 14.9% in the quarter and 10.0% for the six-month period compared to the prior year.
- QuickLabel: Sales rose 22.9% (quarter) and 22.8% (six months), driven by hardware (VIVO and ZEO printers) and consumables.
- T&M: Sales rose 23.0% (quarter) and 7.1% (six months), driven by Ruggedized and Dash products.
- Grass Technologies (GT): Sales declined 4.6% (quarter) and 8.4% (six months) due to lower research product sales.
- Profitability: Operating income increased 24.1% in the quarter and 8.9% for the six months. However, gross margins compressed slightly (41.9% vs. 43.0% prior year quarter) due to product mix and higher manufacturing costs.
- Expenses: SG&A expenses increased 7.9% (quarter) and 10.6% (six months) due to personnel costs, travel, and Sarbanes-Oxley 404 compliance costs (~$60k for the quarter). R&D expenses increased 20.2% (quarter) and 11.8% (six months).
- Cash Flow: Operating cash flow turned negative, using $670,347 for the six months, compared to providing $1.43 million in the prior year. This was driven by increases in accounts receivable and inventory, and a reduction in accounts payable.
Outlook, Risks, and Unusual Items
- Capital Expenditures: The company spent $3.73 million on property, plant, and equipment in the six-month period, including a $3.18 million cash purchase of a property in Rockland, Massachusetts.
- Tax Matters: The effective tax rate increased to 40.0% (from 38.7% prior year) due to lower expected tax credits. The IRS is currently examining returns for fiscal years 2005 and 2006; resolution could materially affect unrecognized tax benefits.
- Stock Split: A 5-for-4 stock split was characterized as a stock dividend in the prior fiscal year, transferring amounts from retained earnings to capital stock.
- Risk Factors: The company highlights the risk of failing to achieve and maintain effective internal controls under Section 404 of the Sarbanes-Oxley Act, which could adversely affect the stock price.
- Backlog: Backlog increased to $6.84 million at the end of the quarter from $5.96 million at year-end.
Investor Verification Checklist
- Inventory Turnover: Verify the impact of slowing inventory turns (3.5 turns vs. 3.6 turns prior year) on future working capital needs.
- Grass Technologies Decline: Assess the sustainability of the sales decline in the GT segment and the company's strategy to reverse it.
- IRS Examination: Monitor the outcome of the IRS examination for fiscal years 2005 and 2006 for potential tax liability adjustments.
- Operating Cash Flow: Review the reversal of negative operating cash flow in subsequent quarters, given the significant cash outflow for inventory and receivables.
- SOX Compliance: Confirm the company's progress in meeting Section 404 internal control requirements to avoid potential stock price volatility.